Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
223.48(c) 221.69(c) 222.96(c) 222.14(c) 222.79(c) Last
1 611 960 1 936 402 1 322 884 1 637 976 2 034 309 Volume
+0.20% -0.80% +0.57% -0.37% +0.29% Change
More quotes
Financials (USD)
Sales 2020 25 612 M
EBIT 2020 11 936 M
Net income 2020 7 180 M
Debt 2020 19 755 M
Yield 2020 2,85%
Sales 2021 26 410 M
EBIT 2021 12 404 M
Net income 2021 8 215 M
Debt 2021 16 522 M
Yield 2021 3,05%
P/E ratio 2020 18,0x
P/E ratio 2021 15,7x
EV / Sales2020 5,90x
EV / Sales2021 5,60x
Capitalization 131 B
More Financials
Company
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc. The United States account for 74.5% of net sales; - other (5%):... 
Sector
Pharmaceuticals
Calendar
04/28Earnings Release
More about the company
Surperformance© ratings of Amgen Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on AMGEN INC.
02/21AMGEN INC : Entry into a Material Definitive Agreement, Financial Statements and..
AQ
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/19AMGEN : Investor Insights Newsletter Q4 2019
PU
02/14AMGEN INC. : Slide show results
CO
02/14AMGEN INC. : Annual results
CO
02/13AMGEN : Ex-dividend day for
FA
02/12AMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
02/11AMGEN : How Two Female Staff Members Found a Career in Science
PU
02/06AMGEN : Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart..
AQ
02/05AMGEN INC. : Report
CO
02/04AMGEN : Staff Share Their Commitment to Cancer Research for World Cancer Day
PU
01/31Health Care Down On Risk Aversion -- Health Care Roundup
DJ
01/31Exxon Mobil, Amgen fall; Amazon, IBM rise
AQ
01/31Amgen Down Over 5%, Worst Performer in the Nasdaq 100 So Far Today -- Data Ta..
DJ
01/31WALL STREET STOCK EXCHANGE : Amazing Amazon
More news
News in other languages on AMGEN INC.
02/13AMGEN : Ex-dividend day for
02/06Molecular Partners steigert 2019 Umsatz aber schreibt weiter Verlust
01/31DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 31.01.2020 - 15.15 Uhr
01/31Les valeurs à suivre vendredi 31 janvier 2020 à Wall Street -
01/31AMGEN : résultats solides mais prévisions prudentes
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Sector news : Pharmaceuticals - NEC
02/21Marriott Hires Former Merck CIO as Tech Chief
DJ
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/21DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
02/21ALLERGAN : Form 8.3 -
DJ
02/21ABBVIE : Form 8.3 -
DJ
More sector news : Pharmaceuticals - NEC
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 245,42  $
Last Close Price 222,79  $
Spread / Highest target 27,9%
Spread / Average Target 10,2%
Spread / Lowest Target -17,0%
EPS Revisions
Managers
NameTitle
Robert A. Bradway Chairman & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
Peter H. Griffith Chief Financial Officer
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN INC.-7.85%131 403
JOHNSON & JOHNSON1.71%395 024
ROCHE HOLDING AG10.08%300 195
NOVARTIS2.89%218 568
MERCK AND COMPANY-9.47%209 636
PFIZER-8.50%197 679